Treatment resistant depression Market Insight, Epidemiology And Market Forecast 2032

 



Treatment-resistant depression (TRD) typically refers to inadequate response to at least one antidepressant trial of adequate doses and duration. Treatment-resistant depression is a relatively common occurrence in clinical practice, with up to 50–60% of the patients not achieving adequate response following antidepressant treatment.

Treatment-Resistant Depression Epidemiology Segmentation in the 7MM 

  • Total Diagnosed Prevalent Cases Treatment-Resistant Depression
  • Age-Specific Cases of Treatment-Resistant Depression
  • Gender-specific Cases of Treatment-Resistant Depression

Treatment-Resistant Depression Epidemiological Insights Observed in the 7MM (2021)

  • The total prevalent cases of Treatment-Resistant Depression in the 7MM were estimated to be 5.8 million.
  • The total prevalent cases of Treatment-Resistant Depression in the US were estimated to be 3.9 million.
  • The total prevalent cases of Treatment-Resistant Depression in Germany was found to be 558k and in Italy, they were found to be 127k in the year 2021.

Treatment-Resistant Depression Market Insight

The market size of Treatment-Resistant Depression in the 7MM was found to be USD 2,450 million in 2021. 

Treatment-Resistant Depression Emerging Therapies

The emerging drugs in the Treatment-Resistant Depression market are

  • AXS-05
  • VRAYLAR
  • Esketamine DPI
  • REL-1017
  • COMP360
  • MIJ821
  • Liafensine
  • MK-1942
  • NV5138
  • TS161
  • AV-101, and many others

Treatment-Resistant Depression Companies

The key players working in the Treatment-Resistant Depression market are

  • Axsome Therapeutics
  • AbbVie
  • Celon Pharma
  • Relmada Therapeutics
  • COMPASS Pathways
  • Novartis
  • Denovo Biopharma
  • Merck Sharp and Dohme Corp
  • Navitor Pharmaceuticals, Inc.
  • Supernus Pharmaceuticals, Inc.
  • Taisho Pharmaceutical Co., Ltd
  • VistaGen Therapeutics, and several others

Related Topics

Treatment resistant depression

Treatment resistant depression Market

Treatment resistant depression infographic

Treatment resistant depression Market Infographic


Comments

  1. DelveInsight Business ConsultingJuly 4, 2022 at 2:06 AM

    https://wiliammark1.blogspot.com/2022/07/trending-popular-market-research.html
    https://michaelpaul11.blogspot.com/2022/07/trending-popular-market-research.html
    https://robertdaniel1.blogspot.com/2022/07/trending-popular-market-research.html
    https://johnchristopher1.blogspot.com/2022/07/trending-popular-market-research.html
    https://jamesthomas1.blogspot.com/2022/07/trending-popular-market-research.html
    https://marketinsightreportss.blogspot.com/2022/07/trending-popular-market-research.html
    https://healthcareconsultingservicess.blogspot.com/2022/07/trending-popular-market-research.html
    https://healthcareconsultingsolutions.blogspot.com/2022/07/trending-popular-market-research.html
    https://businesconsultingservice.blogspot.com/2022/07/trending-popular-market-research.html
    https://delveinsightresearch.blogspot.com/2022/07/trending-popular-market-research.html
    https://forum.mobisystems.com/showthread.php?tid=720
    https://forum.barmyarmy.com/threads/trending-popular-market-research-reports-2022-by-delveinsight.2373/
    http://clashofclansbuilder.com/forums/thread/416103
    http://personalgrowthsystems.ning.com/forum/topics/trending-popular-market-research-reports-2022-by-delveinsight-2

    ReplyDelete

Post a Comment

Popular posts from this blog

Exploring Key Markets in Rare Diseases: A Comprehensive Overview

Image
In the realm of healthcare, the landscape is diverse and complex, with various conditions impacting individuals worldwide. Among these, rare diseases often present unique challenges due to their low prevalence and limited treatment options. In this article, we delve into several rare diseases markets, including Short Bowel Syndrome, Complement 3 Glomerulopathy, Retinitis Pigmentosa, Aplastic Anemia, Nephrotic Syndrome, Pulmonary Arterial Hypertension, Hemophilia A, and Complicated Urinary Tract Infections, highlighting key aspects such as market dynamics, treatment innovations, and future prospects. Short Bowel Syndrome Market Short Bowel Syndrome is a rare disorder characterized by a malfunctioning small intestine, leading to malabsorption of nutrients. The market for SBS therapies has witnessed significant growth in recent years, fueled by advancements in medical technology and increased awareness. Key players in this market are focusing on the development of novel therapies aime
Read more
Image
  What is the  Small Fiber Neuropathy Market ? DelveInsight's  "Small Fiber Neuropathy Market Insights, Epidemiology, and Market Forecast-2032"  report delivers an in-depth understanding of the Small Fiber Neuropathy, historical and forecasted epidemiology as well as the Small Fiber Neuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. What is the  Small Fiber Neuropathy Market Size  Report?  The Small Fiber Neuropathy market report provides current treatment practices, emerging drugs, Small Fiber Neuropathy market share of the individual therapies, current and forecasted Small Fiber Neuropathy market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current Small Fiber Neuropathy treatment practice/algorithm, Small Fiber Neuropathy market drivers, Small Fiber Neuropathy market barriers, and Small Fiber Neuropathy unmet needs to curate the best of the opportunities and assesses the u
Read more